Wednesday, 13 December 2017

Novartis generics arm says may sell or end some products

ZURICH (Reuters) - Swiss drugmaker Novartis's Sandoz generics business is in the process of selling or closing some products in the United States, it said on Wednesday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)